E
BioCardia, Inc.
BCDA
$2.27
$0.136.08%
E
Sell
7/14/2023Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 7/14/2023 due to a decline in the volatility index and valuation index.
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 7/14/2023 due to a decline in the volatility index and valuation index.
D
Sell
6/13/2023Upgraded
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 6/13/2023 due to a noticeable increase in the growth index, volatility index and total return index. Operating cash flow increased 14.58% from -$3M to -$2.56M.
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 6/13/2023 due to a noticeable increase in the growth index, volatility index and total return index. Operating cash flow increased 14.58% from -$3M to -$2.56M.
E
Sell
5/5/2023Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 5/5/2023 due to a decline in the growth index and volatility index. Total revenue declined 50% from $212 to $106, and operating cash flow declined 49.4% from -$2.01M to -$3M.
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 5/5/2023 due to a decline in the growth index and volatility index. Total revenue declined 50% from $212 to $106, and operating cash flow declined 49.4% from -$2.01M to -$3M.
D
Sell
3/29/2023Upgraded
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 3/29/2023 due to an increase in the volatility index and valuation index.
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 3/29/2023 due to an increase in the volatility index and valuation index.
E
Sell
3/14/2023Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D on 03/14/2023.
BioCardia, Inc. (BCDA) was downgraded to E+ from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
BioCardia, Inc. (BCDA) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
BioCardia, Inc. (BCDA) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
D
Sell
2/8/2023Downgrade
BioCardia, Inc. (BCDA) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index, valuation index and solvency index. Total revenue declined 78.23% from $974 to $212, debt to equity increased from 0.04 to 0.07, and the quick ratio declined from 2.89 to 1.89.
BioCardia, Inc. (BCDA) was downgraded to D- from D on 2/8/2023 due to a decline in the growth index, valuation index and solvency index. Total revenue declined 78.23% from $974 to $212, debt to equity increased from 0.04 to 0.07, and the quick ratio declined from 2.89 to 1.89.
D
Sell
5/16/2022Upgraded
BioCardia, Inc. (BCDA) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index, valuation index and total return index.
BioCardia, Inc. (BCDA) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index, valuation index and total return index.
E
Sell
5/13/2022Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D on 5/13/2022 due to a decline in the solvency index, valuation index and total return index. Debt to equity increased from 0.02 to 0.04, and the quick ratio declined from 3.51 to 2.62.
BioCardia, Inc. (BCDA) was downgraded to E+ from D on 5/13/2022 due to a decline in the solvency index, valuation index and total return index. Debt to equity increased from 0.02 to 0.04, and the quick ratio declined from 3.51 to 2.62.
D
Sell
5/4/2022Upgraded
BioCardia, Inc. (BCDA) was upgraded to D from E+ on 05/04/2022.
BioCardia, Inc. (BCDA) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
BioCardia, Inc. (BCDA) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/21/2022Upgraded
BioCardia, Inc. (BCDA) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
BioCardia, Inc. (BCDA) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index and solvency index. Debt to equity increased from 0.01 to 0.02, and the quick ratio declined from 4.25 to 3.51.
BioCardia, Inc. (BCDA) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index and solvency index. Debt to equity increased from 0.01 to 0.02, and the quick ratio declined from 4.25 to 3.51.
D
Sell
11/9/2021Upgraded
BioCardia, Inc. (BCDA) was upgraded to D from E+ on 11/09/2021.
BioCardia, Inc. (BCDA) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D on 11/8/2021 due to a decline in the growth index. Operating cash flow declined 52.15% from -$1.88M to -$2.87M, EBIT declined 17.4% from -$2.97M to -$3.49M, and earnings per share declined from -$0.1792 to -$0.2045.
BioCardia, Inc. (BCDA) was downgraded to E+ from D on 11/8/2021 due to a decline in the growth index. Operating cash flow declined 52.15% from -$1.88M to -$2.87M, EBIT declined 17.4% from -$2.97M to -$3.49M, and earnings per share declined from -$0.1792 to -$0.2045.
D
Sell
1/19/2021Upgraded
BioCardia, Inc. (BCDA) was upgraded to D from D- on 1/19/2021 due to an increase in the total return index and volatility index.
BioCardia, Inc. (BCDA) was upgraded to D from D- on 1/19/2021 due to an increase in the total return index and volatility index.
D
Sell
1/4/2021Downgrade
BioCardia, Inc. (BCDA) was downgraded to D- from D on 1/4/2021 due to a decline in the volatility index and valuation index.
BioCardia, Inc. (BCDA) was downgraded to D- from D on 1/4/2021 due to a decline in the volatility index and valuation index.
D
Sell
12/15/2020Upgraded
BioCardia, Inc. (BCDA) was upgraded to D from D- on 12/15/2020 due to an increase in the volatility index and total return index.
BioCardia, Inc. (BCDA) was upgraded to D from D- on 12/15/2020 due to an increase in the volatility index and total return index.
D
Sell
11/12/2020Downgrade
BioCardia, Inc. (BCDA) was downgraded to D- from D on 11/12/2020 due to a decline in the growth index, volatility index and solvency index. Debt to equity increased from 0.15 to 0.27, operating cash flow declined 53.82% from -$2.34M to -$3.6M, and the quick ratio declined from 2.6 to 1.96.
BioCardia, Inc. (BCDA) was downgraded to D- from D on 11/12/2020 due to a decline in the growth index, volatility index and solvency index. Debt to equity increased from 0.15 to 0.27, operating cash flow declined 53.82% from -$2.34M to -$3.6M, and the quick ratio declined from 2.6 to 1.96.
D
Sell
8/14/2020Upgraded
BioCardia, Inc. (BCDA) was upgraded to D from D- on 8/14/2020 due to an increase in the growth index, solvency index and volatility index. The quick ratio increased from 0.61 to 2.6, earnings per share increased from -$0.6724 to -$0.4634, and EBIT increased 22.46% from -$4.61M to -$3.57M.
BioCardia, Inc. (BCDA) was upgraded to D from D- on 8/14/2020 due to an increase in the growth index, solvency index and volatility index. The quick ratio increased from 0.61 to 2.6, earnings per share increased from -$0.6724 to -$0.4634, and EBIT increased 22.46% from -$4.61M to -$3.57M.
D
Sell
5/1/2020Upgraded
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 5/1/2020 due to an increase in the solvency index, total return index and volatility index.
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 5/1/2020 due to an increase in the solvency index, total return index and volatility index.
E
Sell
4/13/2020Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 4/13/2020 due to a large decline in the efficiency index, valuation index and volatility index. Total capital declined 45.58% from $6.45M to $3.51M.
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 4/13/2020 due to a large decline in the efficiency index, valuation index and volatility index. Total capital declined 45.58% from $6.45M to $3.51M.
D
Sell
10/29/2019Downgrade
BioCardia, Inc. (BCDA) was downgraded to D- from D on 10/29/2019 due to a decline in the volatility index and total return index.
BioCardia, Inc. (BCDA) was downgraded to D- from D on 10/29/2019 due to a decline in the volatility index and total return index.
D
Sell
10/10/2019Upgraded
BioCardia, Inc. (BCDA) was upgraded to D from D- on 10/10/2019 due to a large increase in the efficiency index and valuation index.
BioCardia, Inc. (BCDA) was upgraded to D from D- on 10/10/2019 due to a large increase in the efficiency index and valuation index.
D
Sell
3/29/2019Upgraded
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 3/29/2019 due to an increase in the volatility index and valuation index.
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 3/29/2019 due to an increase in the volatility index and valuation index.
E
Sell
3/13/2019Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 3/13/2019 due to a noticeable decline in the growth index, volatility index and solvency index. Total revenue declined 64.85% from $239 to $84, the quick ratio declined from 3.86 to 1.97, and earnings per share declined from -$0.0841 to -$0.0926.
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 3/13/2019 due to a noticeable decline in the growth index, volatility index and solvency index. Total revenue declined 64.85% from $239 to $84, the quick ratio declined from 3.86 to 1.97, and earnings per share declined from -$0.0841 to -$0.0926.
D
Sell
9/28/2018Upgraded
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 9/28/2018 due to an increase in the volatility index and total return index.
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 9/28/2018 due to an increase in the volatility index and total return index.
E
Sell
8/14/2018Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 8/14/2018 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 4.61 to 3.86.
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 8/14/2018 due to a major decline in the total return index, volatility index and solvency index. The quick ratio declined from 4.61 to 3.86.
D
Sell
1/23/2018Upgraded
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 1/23/2018 due to an increase in the volatility index, total return index and valuation index.
BioCardia, Inc. (BCDA) was upgraded to D- from E+ on 1/23/2018 due to an increase in the volatility index, total return index and valuation index.
E
Sell
12/21/2017Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 12/21/2017 due to a decline in the total return index and volatility index.
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 12/21/2017 due to a decline in the total return index and volatility index.
D
Sell
11/13/2017Upgraded
BioCardia, Inc. (BCDAD) was upgraded to D- from E+ on 11/13/2017 due to an increase in the growth index, efficiency index and valuation index. Total revenue increased 16.07% from $112 to $130, and operating cash flow increased 15.02% from -$2.09M to -$1.78M.
BioCardia, Inc. (BCDAD) was upgraded to D- from E+ on 11/13/2017 due to an increase in the growth index, efficiency index and valuation index. Total revenue increased 16.07% from $112 to $130, and operating cash flow increased 15.02% from -$2.09M to -$1.78M.
E
Sell
8/16/2017Downgrade
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 8/16/2017 due to a decline in the growth index, efficiency index and solvency index. The quick ratio declined from 14 to 10.61, total revenue declined 18.25% from $137 to $112, and total capital declined 12.37% from $18.35M to $16.08M.
BioCardia, Inc. (BCDA) was downgraded to E+ from D- on 8/16/2017 due to a decline in the growth index, efficiency index and solvency index. The quick ratio declined from 14 to 10.61, total revenue declined 18.25% from $137 to $112, and total capital declined 12.37% from $18.35M to $16.08M.
D
Sell
7/5/2017Upgraded
BioCardia, Inc. (BCDA) was upgraded to D- from E on 7/5/2017 due to an increase in the growth index. Earnings per share increased from -$0.0104 to -$0.0063, EBIT increased 17.19% from -$3.47M to -$2.88M, and operating cash flow increased 9.42% from -$2.52M to -$2.28M.
BioCardia, Inc. (BCDA) was upgraded to D- from E on 7/5/2017 due to an increase in the growth index. Earnings per share increased from -$0.0104 to -$0.0063, EBIT increased 17.19% from -$3.47M to -$2.88M, and operating cash flow increased 9.42% from -$2.52M to -$2.28M.
E
Sell
4/18/2017Downgrade
BioCardia, Inc. (BCDA) was downgraded to E from E+ on 4/18/2017 due to a decline in the volatility index and total return index.
BioCardia, Inc. (BCDA) was downgraded to E from E+ on 4/18/2017 due to a decline in the volatility index and total return index.
E
Sell
4/3/2017Upgraded
BioCardia, Inc. (BCDA) was upgraded to E+ from E on 4/3/2017 due to a significant increase in the solvency index and total return index. The quick ratio increased from 0.18 to 14.84.
BioCardia, Inc. (BCDA) was upgraded to E+ from E on 4/3/2017 due to a significant increase in the solvency index and total return index. The quick ratio increased from 0.18 to 14.84.
E
Sell
1/23/2017None
BioCardia, Inc. (BCDA) was downgraded to E from U on 01/23/2017.
BioCardia, Inc. (BCDA) was downgraded to E from U on 01/23/2017.
NASDAQ
04/02/2025 4:00PM Eastern
Quotes delayed
